ChiCTR-INR-17010350
尚未开始
/
/
/
2017-01-06
/
/
动静脉内瘘狭窄
比較折疊球囊導管血管成形術與傳統球囊導管血管成形術的隨機臨床試驗
比較折疊球囊導管血管成形術與傳統球囊導管血管成形術的隨機臨床試驗
The primary objective is to evaluate at post-operation, 1 month, 6 months and 12 months follow-ups the safety and efficacy of scoring balloon for AV Fistula based on primary patency of target lesions in experimental and control groups.
随机平行对照
治疗新技术
60 patients randomized into 2 groups, 30 in experimental group, 30 in control group
Open label
NA
/
30
/
1990-01-01
1990-01-01
/
Percutaneous Transluminal Angioplasty will performed in end-stage renal failure patients with hemodynamically significant (defined as >50%) stenosis of the autogenous fistula.；
请登录查看- Patient refusing treatment - The reference segment diameter is not suitable for available catheter design - Previous PTA for the same lesion - Associated significant (>50%) central venous stenosis - Multiple significant (>50%) stenosis - The patient is minor (<18 years old) - Previous access thrombectomy - Positive pregnancy test result within 7 days before enrolment - Patient is scheduled for a kidney transplant - Life expectancy <6 months - The patient has a known allergy to heparin, aspirin or other anticoagulant/ antiplatelet therapies - The patient is currently enrolled in another investigational device or drug trial - The patient is currently breast-feeding, pregnant or intends to become pregnant；
请登录查看Princess Margaret Hospital
/
Princess Margaret Hospital的其他临床试验
Consultant, Diagnostic Radiology Department, Princess Margaret Hospital的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04